Direktorat Registrasi ObatValid

RINCOBAL

Claim this product
BPOM Number
DKL1432718901A1
Approved
8 August 2025
Expiry
7 August 2030
Form
Capsule

About This Registration

RINCOBAL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1432718901A1. Its current registration status is Valid, with the licence valid until 7 August 2030. The product is registered to YARINDO FARMATAMA and manufactured by YARINDO FARMATAMA - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 10 STRIP @ 10 KAPSUL
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

MECOBALAMIN

Market Intelligence

Owner Portfolio
YARINDO FARMATAMA holds 137 BPOM registrations
Manufacturer Scale
YARINDO FARMATAMA - INDONESIA produces 128 registered products
Registration Age
Registered for 1 year, 1 month

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from YARINDO FARMATAMA

GLUDEPATIC 500

-DKL2632724417A1
Valid
Approved: Apr 10, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717B1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

LEVETIRACETAM

-GKL2632724717A1
Valid
Approved: May 5, 2026TABLET SALUT SELAPUT
View product →

ARIPIPRAZOLE

-GKL2532723035A2
Valid
Approved: Dec 31, 2025CAIRAN ORAL
View product →

VERDON

-DKL2532723917A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

LOZAP

-DKL1433531810A1
Valid
Approved: Jul 19, 2026TABLET
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

CEPHAFLOX

-DKL9908012244B1
Valid
Approved: Jul 4, 2026SERBUK INJEKSI
GUARDIAN PHARMATAMA - INDONESIA
View product →

GABAPENTIN

-GKL2202508001A1
Valid
Approved: Apr 24, 2026KAPSUL
DIPA PHARMALAB INTERSAINS - INDONESIA
View product →

VANCOMYCIN HCL

-GKL2008519844A1
Valid
Approved: Dec 4, 2025SERBUK INJEKSI
HEXPHARM JAYA LABORATORIES - INDONESIA
View product →

DUROGESIC 12 MCG/H

-DNI1155202555A1
Valid
Approved: Nov 6, 2025TRANSDERMAL PATCH
KIMIA FARMA TBK. - INDONESIA
View product →
1